$1.97
0.052.60%
Comments
Loading...
Editas Medicine Earnings Estimates, EPS & Revenue | NASDAQ:EDIT | Benzinga
Editas Medicine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 5
EPS Estimate
$-0.580
Quarterly Revenue Estimate
$19.97M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$61.76M
Analyze the earnings history of Editas Medicine using advanced sorting and filters.
Data brought to you by Benzinga APIs
Editas Medicine (EDIT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-04 | $-0.75 | $-0.78 | 3.85 % |
| Q2 | 2024-08-07 | $-0.82 | $-0.70 | -17.1 % |
| Q1 | 2024-05-08 | $-0.76 | $-0.67 | -13.4 % |
| Q4 | 2024-02-28 | $-0.23 | $-0.54 | 57.4 % |
Editas Medicine (EDIT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-04 | $61.00K | $2.69M | -97.7 % |
| Q2 | 2024-08-07 | $513.00K | $5.08M | -89.9 % |
| Q1 | 2024-05-08 | $1.14M | $7.90M | -85.6 % |
| Q4 | 2024-02-28 | $60.05M | $7.94M | 656.3 % |
FAQ
When is Editas Medicine (NASDAQ:EDIT) reporting earnings?
Editas Medicine (EDIT) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
What were the latest earnings per share (EPS) for Editas Medicine (NASDAQ:EDIT)?
The Actual EPS was $-0.75, which beat the estimate of $-0.78.
What were Editas Medicine’s (NASDAQ:EDIT) revenues?
The Actual Revenue was $61K, which missed the estimate of $2.7M.
Browse earnings estimates, EPS, and revenue on all stocks.